http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-960010008-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 |
| filingDate | 1995-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1996-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-960010008-A |
| titleOfInvention | Aqueous guard suspension |
| abstract | The present invention has a stability constant with respect to cyclodextrin as calculated by the solubility method, having at least 1000 parts by weight of water relative to 1 part by weight of the drug such that a) a cyclotextrin and b) a homogeneous mixture is obtained at 25 ° C. under 1 atmosphere. It relates to an aqueous nasal suspension containing an almost insoluble drug having a value of 1000 or less. The aqueous nasal suspension of the present invention can increase the pharmacological efficacy of drugs that are almost insoluble in water, improve the retention of drugs in the nasal mucosa and sustain drug action, thereby reducing the frequency of administration. Therefore, these nasal suspensions can be used as valuable topical nasal preparations to ensure improved patient dose. |
| priorityDate | 1994-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.